Blog — NephJC

March 23, 2025

Background

Brian Rifkin

KDIGO 2025 ADPKD Guidelines Review

This week, we will discuss the first iteration of KDIGO’s 2025 guidelines on ADPKD. These guidelines are a result of a decade of global collaboration between physicians, researchers, advocates, and patients. The guidelines incorporate ADPKD-specific care as well as many general CKD management practice points.

March 11, 2025

Background

Cristina Adriana Popa

REGENCY: A B-Cell Super Destroyer in Lupus

This week, we will celebrate in advance World Kidney Day by discussing the results of OBInutuzumab in active lupus nephritis. The LUNAR trial (rituximab versus placebo) was “almost” positive, but not quite there. Would Obi overpower its cousin ritux? ✨

February 24, 2025

Background

Cristina Adriana Popa

Hunting Primary Hyperaldosteronism: are MRAs a ...

This week, we will continue with February’s aldosterone leitmotif: do mineralocorticoid receptor antagonists (MRAs) truly blind the diagnostic in unilateral hypraldosteronism? Is this the article the mythbuster? Draw your own conclusions

February 10, 2025

Background

Brian Rifkin

Undercover Aldosterone

This week, we will discuss the origins of primary hyperaldosteronism in normotensive patients. Could this undetected anomaly be the cause of idiopathic hypertension and CKD?

January 21, 2025

Background

swapnil hiremath

HOPE-ing and Coping with Pain in Dialysis

This week, we will discuss the HOPE trial - no not that one - the one in dialysis that was a LBCT in 2024. Should we look beyond analgesics to non-pharmacological options more seriously?

elena cervantes

swapnil hiremath

February 8, 2022

Commentary

Timing Dialysis Right: The Visual Abstract

swapnil hiremath

February 8, 2022

Commentary

Created in a time crunch, the visual abstract for this week’s study from Elena Cervantes:

Guest User

April 19, 2021

Background

Advocating for Patients with Vasculitis: A Steroid-Sparing Regimen with Avacopan

Guest User

April 19, 2021

Background

Advocating for Patients with Vasculitis: A Steroid-Sparing Regimen with Avacopan

This week, we will discuss the ADVOCATE trial. Avacopan is not just a flash in the pan? We hope so, having won the RheumMadness and offering a steroid free hope.

Guest User

March 23, 2021

Commentary

Spin the Urine: The Visual Abstract

Guest User

March 23, 2021

Commentary

Check out the visual abstract for the March 23/24 NephJC by Elena Cervantes.

Then, check out the visual abstract for the two compared studies - the original published work by Priti Meena and a bonus one just for this chat by Jeff Kott !